دورية أكاديمية
أعرض في EDS

CGRP neuropeptide levels in patients with endometriosis-related pain treated with dienogest: a comparative study.

التفاصيل البيبلوغرافية
العنوان: CGRP neuropeptide levels in patients with endometriosis-related pain treated with dienogest: a comparative study.
المؤلفون: Chaichian S; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.; Iranian Scientific Society of Minimally Invasive Gynecology, Tehran, Iran., Firoozabadi ZD; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran., Rokhgireh S; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran., Tahermanesh K; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran., Kashi AM; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.; Iranian Scientific Society of Minimally Invasive Gynecology, Tehran, Iran., Govahi A; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran., Minaeian S; Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran., Mehdizadeh M; Reproductive Sciences and Technology Research Center, Department of Anatomy, Iran University of Medical Sciences, Tehran, Iran., Ajdary M; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran. ajdari.m@iums.ac.ir.
المصدر: BMC women's health [BMC Womens Health] 2024 Apr 24; Vol. 24 (1), pp. 257. Date of Electronic Publication: 2024 Apr 24.
نوع المنشور: Journal Article; Comparative Study; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101088690 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6874 (Electronic) Linking ISSN: 14726874 NLM ISO Abbreviation: BMC Womens Health Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BioMed Central, 2001-
مواضيع طبية MeSH: Nandrolone*/*analogs & derivatives, Endometriosis*/drug therapy , Endometriosis*/complications , Endometriosis*/blood , Nandrolone*/therapeutic use , Nandrolone*/administration & dosage , Calcitonin Gene-Related Peptide*/blood , Pelvic Pain*/drug therapy , Pelvic Pain*/etiology , Pelvic Pain*/blood, Humans ; Female ; Adult ; Pain Measurement ; Chronic Pain/drug therapy ; Chronic Pain/etiology ; Young Adult
مستخلص: Background and Objective: Endometriosis (EM) involves the peripheral nervous system and causes chronic pain. Sensory nerves innervating endometriotic lesions contribute to chronic pain and influence the growth phenotype by releasing neurotrophic factors and interacting with nearby immune cells. Calcitonin gene-related peptide (CGRP), a pain-signaling neurotransmitter, has a significant role. This study examines the effect of Dienogest (DNG), a hormone therapy used for managing EM -related pain, on serum CGRP levels in EM patients.
Materials and Methods: The Visual Analog Scale (VAS) assessed pain in diagnosed EM.
Individuals: Serum samples were obtained to measure CGRP concentration. Participants received a 2 mg/day oral dose of DNG for six months as prescribed treatment. Additional serum samples were collected after this period to measure CGRP levels.
Results: In the EM group, 6.7%, 33.3%, and 20% had ovarian EM, ovarian plus uterosacral, and ovarian plus bladder, respectively. The EM group showed higher CGRP serum levels than the control group (80.53 ± 16.13 vs. 58.55 ± 6.93, P < 0.0001). Still, after drug administration, CGRP serum levels significantly decreased compared to pre-treatment levels (69.66 ± 11.53 vs. 80.53 ± 16.13, P < 0.05). The EM group showed higher pain compared to the control group (7.93 ± 1.58 vs. 0.13 ± 0.35, P < 0.0001), but after drug administration, pain significantly decreased compared to pre-treatment levels (1.00 ± 2.00 vs. 7.93 ± 1.58, P < 0.05).
Conclusion: DNG administration reduces pain and serum CGRP levels in EM patients, offering the potential for innovative treatments and tailored options. Understanding neurotransmitter roles and drug effects can aid in discovering more effective modulators for these pathways.
(© 2024. The Author(s).)
References: Am J Obstet Gynecol. 1996 Sep;175(3 Pt 1):638-42. (PMID: 8828427)
FEBS Open Bio. 2021 Jan;11(1):300-311. (PMID: 33155431)
Acta Ophthalmol. 2024 May;102(3):349-356. (PMID: 37565361)
Pain. 2007 Nov;132 Suppl 1:S26-S45. (PMID: 17964077)
Hum Reprod. 2010 Mar;25(3):633-41. (PMID: 20089522)
Genes (Basel). 2020 Feb 29;11(3):. (PMID: 32121467)
N Engl J Med. 2004 Mar 11;350(11):1073-5. (PMID: 15014178)
Neurol Clin. 2019 Nov;37(4):631-649. (PMID: 31563224)
Int J Mol Sci. 2023 Jul 26;24(15):. (PMID: 37569369)
Cephalalgia. 2021 Dec;41(14):1413-1426. (PMID: 34407650)
J Minim Invasive Gynecol. 2009 May-Jun;16(3):340-3. (PMID: 19423065)
J Pain. 2023 May;24(5):782-795. (PMID: 36509176)
Physiol Rev. 2004 Jul;84(3):903-34. (PMID: 15269340)
Arch Gynecol Obstet. 2023 Oct;308(4):1327-1340. (PMID: 37405438)
Semin Reprod Med. 2012 Jan;30(1):39-45. (PMID: 22271293)
Sci Transl Med. 2021 Aug 25;13(608):. (PMID: 34433639)
Eur J Pain. 2006 May;10(4):287-333. (PMID: 16095934)
Aging (Albany NY). 2020 Apr 10;12(7):6370-6384. (PMID: 32276265)
J Cell Biochem. 2017 Mar;118(3):510-517. (PMID: 27579553)
Physiol Rev. 2014 Oct;94(4):1099-142. (PMID: 25287861)
Int J Mol Sci. 2023 Feb 21;24(5):. (PMID: 36901685)
Int J Mol Sci. 2022 Jan 14;23(2):. (PMID: 35055082)
Ann N Y Acad Sci. 1992 Jun 30;657:505-6. (PMID: 1379022)
PLoS One. 2014 Nov 10;9(11):e112466. (PMID: 25383884)
J Neurosci. 2003 Feb 1;23(3):807-15. (PMID: 12574409)
Ann Clin Transl Neurol. 2021 Jun;8(6):1251-1259. (PMID: 33934575)
Nat Genet. 2023 Mar;55(3):423-436. (PMID: 36914876)
Eur J Pain. 2010 Jul;14(6):602-7. (PMID: 19948419)
Pain Manag. 2011 May;1(3):229-38. (PMID: 24646389)
Cureus. 2023 Feb 17;15(2):e35109. (PMID: 36945265)
Malays J Med Sci. 2022 Apr;29(2):18-30. (PMID: 35528812)
معلومات مُعتمدة: 1400-2-65-21905 Iran University of Medical Sciences
فهرسة مساهمة: Keywords: CGRP; Dienogest; Endometriosis; Pain
المشرفين على المادة: 46M3EV8HHE (dienogest)
6PG9VR430D (Nandrolone)
JHB2QIZ69Z (Calcitonin Gene-Related Peptide)
تواريخ الأحداث: Date Created: 20240424 Date Completed: 20240425 Latest Revision: 20240427
رمز التحديث: 20240427
مُعرف محوري في PubMed: PMC11040845
DOI: 10.1186/s12905-024-03095-y
PMID: 38658933
قاعدة البيانات: MEDLINE
الوصف
تدمد:1472-6874
DOI:10.1186/s12905-024-03095-y